Delivery Order SPE2DB22D3501-SPE2DB24FVY53
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $11,704.80 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division to procure 4,564,711,688 units of Glucagon 1 mg emergency kits. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp a Firm Fixed Price Delivery Order contract valued at $1,126.08 for the supply of 4565391930 GLUCAGON 1 MG EMERGENCY KITS. This contract has an ultimate completion date of August 9, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supports various government agencies and healthcare programs through its extensive federal contracting activities. The company has been awarded multiple Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,764.56, is for the delivery of 4,567,521,744 units of GLUCAGON 1 MG EMERGENCY KITS. It is a firm fixed-price delivery order contract with a completion date of March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $1,141.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of 4,567,576,158 GLUCAGON 1 MG EMERGENCY KITS, with a completion date of March 14, 2025. The contract is a Delivery Order on a Firm Fixed Price basis, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,921.51 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4,564,050,164 units of Glucagon 1 mg emergency kits, with a performance period ending on March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- This federal contract award, valued at $4,108.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,592,750 GLUCAGON 1 MG EMERGENCY KITS, with a firm fixed price and an ultimate completion date of March 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,347.74 firm fixed-price delivery order is for the provision of 4,567,421,551 units of GLUCAGON 1 MG EMERGENCY KITS, with a period of performance through March 3, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,664,775 Glucagon 1 mg Emergency Kits. The order has a potential value of $1,544.80 and a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside contract. The award is part of a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,161,248 Glucagon 1 mg Emergency Kits. The contract has an ultimate completion date of April 4, 2024 and a ceiling value of $4,634.40. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The U.S. government awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,555,585,805 Glucagon 1 mg Emergency Kits. The $1,743.94 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has an ultimate completion date of December 6, 2021. This delivery order is issued under Amerisourcebergen's primary $999,999,999.00 indefinite...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVY53Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $2,785.20 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of 4,564,885 units of GLUCAGON 1 MG EMERGENCY KITS. This contract has an ultimate completion date of June 13, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA). The company holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical and medical supplies to DLA facilities supporting the DoD worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was made on a full and open competition basis without a set-aside designation, indicating Amerisourcebergen's strong competitive position in the federal pharmaceutical supply market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 6/12/24 |